Assessment of labelled products with different radioanalytical methods: study on 18F-fluorination reaction of 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-2-pyridinyl-benzamide (p-[18F]MPPF)

The serotonin receptor 5-HT1A ligand 4-[18F]fluoro-N-[2-[1-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-2-pyridinyl-benzamide (p-[18F]MPPF) was produced by a simplified method of Le Bars et al. Traditional oil bath heating was compared to microwave heating. Various radioanalytical methods, radio-Thin Layer Chromatography (TLC), High Pressure Liquid Chromatography (HPLC) and Mass Spectrometry (MS), were compared in the evaluation of the labelled product(s). The crude reaction mixture consisted of p-[18F]MPPF and 2–4 radioactive by-products eluting after the product fraction, and the reverse-phase HPLC method failed occasionally to separate p-[18F]MPPF from the radioactive by-product with close retention time. The heating method had no significant effect on the composition of labelled by-products. In LC-(ESI)-MS analysis of p-[18F]MPPF the labelled product was identified with m/z ratio of 435 ([M + H+]). The other HPLC fractions were measured to have following m/z ratios: (1) 327; 349; (675) (2) 402; 407/408; (791) and (3) 436, suggesting different kind of decomposition of the labelled product and/or the inactive precursor. The ion trap mass spectrometer was sufficient for the qualitative analysis of p-[18F]MPPF. However, differentiation of by-products arising from the decomposition of p-[18F]MPPF or from its precursor p-MPPNO2 proved to be challenging.

[1]  K. Markides,et al.  On the use of liquid chromatography with radio- and ultraviolet absorbance detection coupled to mass spectrometry for improved sensitivity and selectivity in determination of specific radioactivity of radiopharmaceuticals. , 1999, Journal of pharmaceutical and biomedical analysis.

[2]  H. Kung,et al.  Synthesis and evaluation of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- iodobenzamido]ethyl]piperazine (p-MPPI): a new iodinated 5-HT1A ligand. , 1994, Journal of medicinal chemistry.

[3]  D. Le Bars,et al.  In vivo characterization of p‐[18F]MPPF, a fluoro analog of WAY‐100635 for visualization of 5‐HT1a receptors , 2000, Synapse.

[4]  Merja Haaparanta,et al.  Analysis of 18F-labelled synthesis products on TLC plates: comparison of radioactivity scanning, film autoradiography, and a phosphoimaging technique. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[5]  A. Luxen,et al.  Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats. , 2006, Nuclear Medicine and Biology.

[6]  Ying Ma,et al.  Application of LC-MS to the analysis of new radiopharmaceuticals. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[7]  G. Slegers,et al.  In vivo evaluation of 4-[123I]iodo-N-[2[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl]benzamide, a potential SPECT radioligand for the 5-HT1A receptor. , 2001, Nuclear medicine and biology.

[8]  C. Poole.  Thin-layer chromatography: challenges and opportunities. , 2003, Journal of chromatography. A.

[9]  W Vaalburg,et al.  In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  W C Eckelman,et al.  Development of fluorine-18-labeled 5-HT1A antagonists. , 1999, Journal of medicinal chemistry.

[11]  Jogeshwar Mukherjee,et al.  Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  D Comar,et al.  High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. , 1998, Nuclear medicine and biology.

[13]  H. Kung,et al.  p‐[18F]‐MPPF: A potential radioligand for PET studies of 5‐HT1A receptors in humans , 1997, Synapse.

[14]  G. Kauffman.  American Chemical Society Directory of Graduate Research. By The ACS Committee on Professional Training; American Chemical Society: Washington, DC, 1997. xv + 1708 pp. 21.4 × 28.3 cm. $65.00 HB ISBN 0-8412-3544-9 , 1999 .